Bartholin's Cyst Treatment in India
Get Bartholin's Cyst Treatment at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Bartholin's Cyst Treatment in UAE
Bartholin's Cyst Treatment at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Bartholin's cyst treatment encompasses a spectrum of interventions—from conservative sitz-bath management and antibiotic therapy to Word catheter insertion, marsupialization, and gland excision—selected according to cyst size, recurrence history, and patient anatomy. Clinical success rates for definitive surgical procedures such as marsupialization exceed 85–95%, with recurrence rates below 10% when performed by experienced gynecological surgeons. International patients choose India and the UAE through GAF Healthcare for access to NABH- and JCI-accredited facilities, subspecialty-trained gynecologists, and end-to-end medical travel coordination at a fraction of Western costs.
Hospital Stay: 0–2 days (day-surgery for Word catheter/marsupialization; 1–2 days for gland excision under general anesthesia) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (minor procedures: 7 days; gland excision or complicated cases: up to 14 days before safe international travel) • Success Rate: 85–95% (procedure-dependent; marsupialization and gland excision carry the highest long-term cure rates)
What Is It?
The Bartholin glands (greater vestibular glands) are a bilateral pair of pea-sized mucus-secreting glands situated at the 4 o'clock and 8 o'clock positions of the vaginal introitus. Their primary function is lubrication of the vestibule during sexual arousal. When the narrow 2.5 cm excretory duct becomes obstructed—due to inspissated mucus, low-grade infection, trauma, or congenital narrowing—secretion accumulates and a cystic cavity forms within the gland, producing a Bartholin's cyst. Cysts range from 1–8 cm in diameter; smaller asymptomatic cysts may require no intervention, while larger lesions cause significant vulvar discomfort, dyspareunia, difficulty walking, and impaired sitting. If secondary bacterial colonization occurs—commonly with polymicrobial flora, Escherichia coli, Staphylococcus aureus, Neisseria gonorrhoeae, or Chlamydia trachomatis—the cyst rapidly evolves into a Bartholin's abscess characterized by acute, exquisitely tender, fluctuant swelling with surrounding erythema and systemic signs of infection.
From a physiological standpoint, untreated obstruction perpetuates a cycle of ductal fibrosis and recurrent cyst formation. In women over 40 years of age, any solid or complex Bartholin gland mass must be evaluated with targeted biopsy to exclude the rare but clinically important Bartholin gland carcinoma (adenocarcinoma or squamous cell carcinoma, accounting for approximately 1–2% of all vulvar malignancies). Standard diagnostic workup therefore integrates clinical examination, high-resolution transvaginal or perineal ultrasound, and—when malignancy cannot be excluded—MRI of the pelvis with gadolinium contrast and histopathological biopsy. Sexually transmitted infection (STI) screening via NAAT (nucleic acid amplification testing) for gonorrhea and chlamydia, vaginal culture and sensitivity, and a full blood count with CRP are essential adjuncts to guide antibiotic selection.
The current standard of care follows a stepwise, patient-individualized algorithm endorsed by the Royal College of Obstetricians and Gynaecologists (RCOG) and the American College of Obstetricians and Gynecologists (ACOG). Asymptomatic cysts in women under 40 are managed expectantly with warm sitz baths (10–15 minutes, 3–4 times daily). Symptomatic or infected cysts warrant surgical drainage, with the choice of technique—simple incision and drainage (I&D), Word catheter insertion, silver nitrate or alcohol sclerotherapy, CO₂ laser marsupialization, or formal gland excision—determined by abscess vs. cyst status, recurrence pattern, patient age, and surgeon expertise. Antibiotic therapy is adjunctive, not curative for the obstructed duct itself.
Candidates
• ELIGIBLE PATIENTS:
• Women of any reproductive age (typically 20–40 years) with a symptomatic Bartholin's cyst ≥2 cm causing pain, dyspareunia, or functional impairment
• Patients with a confirmed Bartholin's abscess requiring urgent surgical drainage
• Women with recurrent Bartholin's cysts (≥2 episodes) for whom definitive procedures (marsupialization or excision) are indicated
• Postmenopausal women with any new Bartholin gland enlargement (mandatory biopsy to exclude carcinoma before definitive treatment)
• Patients who have failed conservative management (sitz baths ± antibiotics) over 2–4 weeks
• Women with a history of Word catheter failure or sclero-therapy non-response who are candidates for marsupialization
• REQUIRED DIAGNOSTIC WORKUP:
• Detailed gynecological history and physical examination (size, consistency, tenderness, laterality, skin changes)
• Perineal/transvaginal ultrasound: to differentiate simple cyst (anechoic, thin-walled) from abscess (echogenic internal debris, septations) or complex solid mass
• Pelvic MRI with gadolinium (T1/T2 sequences): mandatory in women >40 years or when ultrasound findings are atypical, to exclude Bartholin gland carcinoma, Skene's duct cyst, or fibroma
• NAAT swab (cervical/vaginal): for Neisseria gonorrhoeae and Chlamydia trachomatis
• Vaginal and cervical culture with antibiotic sensitivity (particularly for abscess cases)
• Full blood count (FBC), CRP/ESR, HbA1c (diabetes screening—diabetic patients have higher abscess recurrence risk)
• Biopsy/histopathology: excised cyst wall sent for pathology in all patients >40 years (mandatory) and in any patient with atypical gross appearance
• Coagulation screen (PT, aPTT, INR): required pre-operatively for patients on anticoagulants or with bleeding history
• STI panel: HIV, syphilis serology, hepatitis B surface antigen—standard pre-surgical workup
• CONTRAINDICATIONS / CAUTIONS:
• Active severe systemic sepsis without prior IV antibiotic stabilization (surgery deferred until hemodynamically stable)
• Uncontrolled coagulopathy or anticoagulation that cannot be safely bridged
• Confirmed Bartholin gland malignancy: requires radical surgical oncology referral (wide local excision ± inguinofemoral lymph node dissection), not standard cyst surgery
• Pregnancy (relative contraindication for elective excision; abscess drainage under local anesthesia is safe; timing of elective procedures deferred to postpartum)
• Severe perineal anatomical distortion from prior surgery or radiation (increased excision risk; specialist assessment required)
Procedure
CONSERVATIVE MANAGEMENT (First-Line for Asymptomatic/Small Cysts) Warm sitz baths (40°C water, 15 minutes, 3–4 times daily) promote spontaneous ductal drainage in 20–30% of small, non-infected cysts. Topical or systemic antibiotics are added only when infection is confirmed by culture; empiric broad-spectrum therapy (amoxicillin-clavulanate or doxycycline + metronidazole to cover mixed aerobic-anaerobic and STI pathogens) is initiated pending sensitivity results. Analgesics (NSAIDs: ibuprofen 400–600 mg TDS) provide symptomatic relief.
SIMPLE INCISION & DRAINAGE (I&D) — Lowest Recurrence Benefit Performed under local anesthesia (lignocaine 1–2% infiltration) in an outpatient setting. A stab incision is made over the mucosal aspect of the cyst, contents evacuated, and the cavity irrigated with saline. Recurrence rates are high (≈50–70%) because the ductal obstruction is not corrected. I&D is therefore reserved for acute abscess decompression as a temporizing measure in systemically unwell patients.
WORD CATHETER INSERTION — Standard Outpatient Procedure A Word catheter (a small balloon-tipped latex catheter, size 10–16 Fr) is inserted through a 3–5 mm stab incision into the cavity after drainage. The balloon (2–3 mL saline) is inflated to maintain patency, and the catheter is left in situ for 4–6 weeks, allowing epithelialization of a new duct opening. Success rates for first insertion: 55–75%; re-insertion after failure raises cumulative success. The procedure takes <10 minutes under local anesthesia and is the first-line surgical approach in pre-menopausal women with a first-episode symptomatic cyst or abscess.
SILVER NITRATE / ALCOHOL SCLEROTHERAPY — Minimally Invasive Alternative After drainage, the cyst cavity is injected with 70% ethanol (3–5 mL, aspirated after 5 minutes) or packed with silver nitrate sticks. The sclerosant induces fibrosis and obliteration of the cavity, preventing fluid re-accumulation. Reported cure rates: 65–90%. Advantages include avoidance of the protruding catheter; disadvantages include chemical burn risk and variable evidence quality. This technique is increasingly used in patients who find the Word catheter socially inconvenient.
MARSUPIALIZATION — Gold Standard for Recurrent Cysts Performed under spinal or general anesthesia in an operating theatre. An elliptical incision (2–3 cm) is made over the inner labium minus overlying the cyst, the cyst wall is opened, and its everted edges are sutured to the overlying vaginal skin with interrupted 2/0 Vicryl or PDS sutures—creating a permanent new ostium through which gland secretions drain continuously. This anatomically preserves the functional gland. Operative time: 20–45 minutes. Recurrence rate: 5–15%. Recovery: 2–4 weeks for complete wound healing. Marsupialization is the procedure of choice for recurrent cysts/abscesses and is the most commonly performed definitive intervention worldwide.
CO₂ LASER MARSUPIALIZATION — Advanced Minimally Invasive Technique Available in select tertiary centers in India (Apollo, Fortis, Manipal) and the UAE (Mediclinic City Hospital, Cleveland Clinic Abu Dhabi). The CO₂ laser (10,600 nm wavelength) simultaneously incises tissue and vaporizes the cyst wall with hemostatic precision, reducing intraoperative blood loss, postoperative edema, and wound healing time by approximately 30–40% compared to cold-knife marsupialization. Ideal for patients with coagulation concerns or those seeking faster return to activity.
BARTHOLIN GLAND EXCISION (Glandectomy) — Definitive for Refractory/Suspicious Cases Complete surgical removal of the Bartholin gland, duct, and cyst under general or spinal anesthesia. Indicated for: (1) multiple recurrences despite marsupialization; (2) women >40 with suspicious histological features; (3) failed sclerotherapy or Word catheter. Operative time: 30–60 minutes. Risks include: hemorrhage from the vestibular bulb vasculature, hematoma formation, and permanent loss of ipsilateral gland lubrication (mitigated by contralateral gland). All excised specimens undergo mandatory histopathology. Recovery: 3–6 weeks. Recurrence rate: <5%.
TECHNOLOGY & QUALITY STANDARDS Leading hospitals in both India and the UAE utilize high-definition operative endoscopy suites, harmonic scalpel technology for hemostasis in excision cases, and intraoperative culture swabs for targeted post-operative antibiotic stewardship. Intraoperative nerve-sparing dissection is practiced to preserve pudendal nerve branches and avoid dyspareunia or perineal numbness post-excision.
Cost of Bartholin's Cyst Treatment: India vs. UAE
The cost of Bartholin's cyst treatment varies significantly based on the chosen procedure (conservative management vs. Word catheter insertion vs. marsupialization vs. gland excision), anesthesia type, hospital tier, and duration of stay. India offers highly competitive pricing—typically 40–60% below UAE costs—while maintaining equivalent surgical outcomes at NABH- and JCI-accredited institutions. The UAE commands a premium reflective of its luxury infrastructure, cutting-edge technology, and geographic convenience for patients from the Middle East, Africa, and Europe. Both destinations offer transparent, package-based pricing through GAF Healthcare, inclusive of surgeon fees, operating theatre charges, standard post-operative medications, and nursing care.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $500 – $2,500 | ~52% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $1,200 – $5,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PRE-ARRIVAL (2–4 Weeks Before Travel)
• Remote consultation via GAF Healthcare's secure telemedicine platform: gynecologist reviews uploaded ultrasound/MRI reports, STI results, and blood work
• GAF Healthcare coordinator confirms procedure type, hospital, and surgeon allocation
• e-Medical Visa application initiated (India) or entry visa/UAE visa on arrival processed
• Pre-operative instructions issued: cessation of aspirin/NSAIDs 7 days pre-op, anticoagulant bridging protocol if applicable, bowel preparation guidelines
• Travel insurance confirmation with repatriation cover recommended
DAY 1 – ARRIVAL & PRE-OPERATIVE ASSESSMENT
• Airport reception by GAF Healthcare's dedicated driver; transfer to hotel or hospital guest house
• Same-day or next-morning outpatient pre-operative workup: repeat FBC, coagulation screen, urine analysis, ECG (if general anesthesia planned), anesthesia fitness assessment
• Gynecology consultant review: examination under adequate lighting, confirmation of procedure plan, informed consent process including discussion of risks, alternatives, and expected outcomes
• Nil by mouth from midnight if general/spinal anesthesia is planned
DAY 2 – PROCEDURE DAY
• Minor procedures (Word catheter under local anesthesia, sclerotherapy): performed in outpatient minor-ops suite; duration 10–20 minutes; patient discharged 1–2 hours post-procedure
• Marsupialization under spinal anesthesia: admitted to day-surgery unit; procedure 20–45 minutes; 4–6 hours observation post-operatively; discharged same day or overnight stay
• Gland excision under general anesthesia: 1–2 night inpatient stay; IV antibiotics commenced; urinary catheter removed within 12–24 hours; mobilization same evening
• Histopathology sample dispatched to accredited pathology laboratory
DAY 3–7 – EARLY RECOVERY (INPATIENT TO OUTPATIENT)
• Wound inspection at 48–72 hours: nursing assessment of hemostasis, edema, and discharge character
• Transition to oral analgesia (ibuprofen 400 mg TDS + paracetamol 1 g QID); opioids rarely required beyond 24 hours
• Targeted oral antibiotics based on culture sensitivity results (typically 5–7 day course)
• Sitz bath protocol resumed: 3× daily with warm water + dilute povidone-iodine or plain saline to promote wound hygiene and reduce edema
• Word catheter patients: catheter remains in situ; instruction on daily care and hygiene
• Histopathology result review with gynecologist (typically available within 3–5 working days)
• Dietary guidance: high-fiber diet and adequate hydration to avoid constipation and perineal straining
DAY 7–14 – PRE-DEPARTURE RECOVERY MILESTONE
• Surgical wound review: satisfactory healing confirmed (reduced erythema, no purulent discharge, wound edges approximating)
• Fit-to-fly assessment by treating gynecologist: certified medically safe to travel once wound is healing well, systemic infection resolved, and patient ambulatory without significant pain
• Word catheter removal scheduled (if 4–6 week in-situ protocol not feasible, patient educated on remote removal by local gynecologist at home)
• Discharge summary, operative note, histopathology report, and medication prescription provided in English (and Arabic translation if required for UAE patients)
• GAF Healthcare coordinator arranges airport transfer and confirms onward flight booking
WEEKS 2–6 – HOME RECOVERY
• Avoid sexual intercourse, tampon use, and strenuous perineal activity for minimum 4 weeks post-marsupialization or excision
• Sitz baths continued 2× daily until wound fully epithelialized
• Follow-up teleconsultation with GAF Healthcare-linked gynecologist at 2 weeks and 6 weeks post-procedure
• Return to desk work: 3–5 days (minor procedures), 1–2 weeks (marsupialization/excision)
• Return to full physical activity (including exercise and intercourse): 4–6 weeks
• Alert signs requiring urgent local medical review: fresh bleeding, fever >38°C, rapidly worsening pain, or wound dehiscence
Risks & Considerations
Bartholin's cyst and abscess procedures carry a favorable safety profile but are not without risk, and patients must receive a thorough informed consent discussion. Intraoperative risks include hemorrhage from the highly vascular vestibular bulb (risk elevated in excision procedures; estimated blood loss typically <100 mL for marsupialization but can exceed 500 mL in complex excisions), inadvertent entry into the rectum or vaginal epithelium during sharp dissection, and anesthetic complications proportional to the type of anesthesia used. Post-operative complications include: wound infection or abscess recurrence (5–15% for marsupialization; highest with simple I&D at 50–70% recurrence); hematoma formation requiring surgical drainage (2–5% of excision cases); wound dehiscence, particularly in immunocompromised or diabetic patients; dyspareunia or perineal numbness from pudendal nerve branch traction (transient in most cases, resolving within 6–12 weeks); and scarring affecting introital elasticity. Specific to Word catheter management: premature balloon deflation or catheter expulsion occurs in 10–15% of cases, necessitating re-insertion. Sclerotherapy carries a risk of chemical cellulitis if the sclerosant extravasates beyond the cyst wall. In women over 40, the critical risk is delayed diagnosis of underlying Bartholin gland carcinoma—a rare but serious malignancy that can masquerade as a benign cyst; mandatory histopathology of all excised tissue in this age group is a non-negotiable quality standard enforced at all GAF Healthcare partner hospitals. Patients with diabetes, immunosuppression, or prior pelvic radiation should be counseled regarding significantly elevated infection, wound healing, and recurrence risks.
Top Hospitals for Bartholin's Cyst Treatment
The following JCI and NABH-accredited hospitals are among the most experienced in specialist care, with dedicated teams and high-volume programmes.
Manipal Hospitals Dwarka
New Delhi, India
Burjeel Hospital for Advanced Surgery Dubai
Dubai, UAE
Kings College Hospital Dubai
Dubai, UAE
Aster Hospital Dubai
Dubai, UAE
Top Doctors for Bartholin's Cyst Treatment
Internationally trained specialists in Gynecology. Review their profiles, compare experience, and connect directly through GAF Healthcare.
Dr. Tarang Preet Kaur
MBBS, MS, MRCOG, MCh, Fellowship in Urogynaecology, Fellowship in Cosmetic Gynaecology
Urogynaecologist
Max Super Speciality Hospital, Saket, New Delhi, India
11+ Yearsof experience
Dr. Tarang Preet Kaur is a Consultant in Urogynaecology with over 11 years of clinical experience, currently practicing at Max Super Speciality Hospital, Saket in New Delhi. She holds an MCh in Urogynaecology from Edge Hill University, United Kingdom (2024), the MRCOG from the Royal College of Obstetricians & Gynaecologists, and an MS in Obstetrics & Gynaecology from Maulana Azad Medical College, Delhi. Her dual qualification across India and the UK… Read more
Dr. Amrinder Kaur Bajaj
MBBS, MD — Obstetrics & Gynaecology (Gold Medalist), Senior Residency — Obstetrics & Gynaecology, FRSH — Fellow of the Royal Society of Health, FIAMS — Fellow of the Indian Association of Medical Specialists
Obstetrician & Gynaecologist
Fortis Hospital, Gurgaon, Gurgaon, India
42+ Yearsof experience
Dr. Amrinder Kaur Bajaj is one of Delhi-NCR's most experienced gynaecologists, with over four decades spent caring for women at every stage of life. She currently practises as a Consultant in Obstetrics & Gynaecology at Fortis Hospital, Gurgaon, where she brings together deep clinical knowledge and a quietly reassuring bedside manner that patients — and their families — find genuinely comforting. Her academic journey set a high bar early on. She completed… Read more
Dr. Anuradha Khurana
MBBS, DGO (Diploma in Obstetrics & Gynaecology), PG in High Risk Pregnancy and Infertility
Gynecologist & Obstetrics Specialist
Artemis Hospital, New Delhi, India
20+ Yearsof experience
Dr. Anuradha Khurana is a Senior Consultant in Obstetrics and Gynecology at Artemis Hospital, Delhi, with over two decades of hands-on experience in women's health. She is particularly well regarded for her work in high-risk pregnancy management, uterine conditions like fibroids and endometriosis, and complex gynecological surgeries. Patients and families consistently describe her as someone who takes the time to truly listen — and to explain things in a… Read more
Dr. Aswari Kesari Kapoor
MBBS, DGO (Diploma in Gynaecology & Obstetrics), CPS (College of Physicians and Surgeons), DNB (Diplomate of National Board) — Obstetrics & Gynaecology
Obstetrician & Gynecologist
Indraprastha Apollo Hospital, New Delhi, India
23+ Yearsof experience
Dr. Aswari Kesari Kapoor is a seasoned Obstetrician and Gynecologist with over 23 years of hands-on clinical experience. She practices at Indraprastha Apollo Hospital in New Delhi — one of India's most respected multi-specialty institutions. Over the course of her career, she has built a strong reputation for managing complex gynecological conditions alongside high-risk pregnancies, all with a calm and reassuring bedside manner that patients consistently… Read more
Dr. Bindhu K S
MBBS, DNB (Obstetrics & Gynecology), Fellowship in Minimal Access Surgery, FICOG (Fellowship of the Indian College of Obstetricians and Gynaecologists), Certificate in Gynecologic and Obstetric Sonography, Certificate in Appreciation of Well Being in Fetal Heart Disease
Obstetrician & Gynecologist
Apollo Hospitals, Navi Mumbai, Mumbai, India
23+ Yearsof experience
Dr. Bindhu K S is a seasoned Obstetrician and Gynecologist based in Mumbai, currently practicing at Apollo Hospitals, Navi Mumbai. With over two decades of clinical experience, she brings together expertise in both obstetrics and advanced minimally invasive gynecologic surgery. Whether a patient comes with a complex fibroid, troublesome endometriosis, or a high-risk pregnancy, Dr. Bindhu approaches each situation with careful thought and genuine care. Her… Read more
Frequently Asked Questions — Bartholin's Cyst Treatment
The total cost of Bartholin's cyst treatment depends on the specific procedure selected. In India, costs typically range from USD 500 to USD 2,500: a Word catheter insertion or outpatient marsupialization under local anesthesia falls at the lower end (USD 500–900), while a formal Bartholin gland excision under general anesthesia at a JCI-accredited hospital in Delhi, Mumbai, or Chennai ranges from USD 1,200–2,500, inclusive of surgeon's fee, operating theatre charges, anesthesia, 1–2 nights of inpatient care, and standard post-operative medications. In the UAE (Dubai or Abu Dhabi), equivalent procedures cost USD 1,200–5,000: Word catheter or outpatient marsupialization runs USD 1,200–2,200, and gland excision at JCI-accredited centers such as Cleveland Clinic Abu Dhabi or Mediclinic City Hospital ranges from USD 2,500–5,000. India is therefore approximately 50–60% more affordable than the UAE for this procedure. Both destinations offer transparent package pricing through GAF Healthcare, and our coordinators provide a detailed personalized cost estimate within 48 hours of receiving your medical records.
The required in-country recovery period depends on the procedure performed. For a Word catheter insertion or alcohol sclerotherapy under local anesthesia—both outpatient procedures—most patients are assessed as fit to fly within 5–7 days, allowing time for the wound to stabilize, a 48-hour infection surveillance window, and review of any culture results. For marsupialization under spinal or general anesthesia, a minimum in-country stay of 7–10 days is recommended: this allows for a formal wound check at 5–7 days, confirmation of adequate healing, and clearance by the treating gynecologist. For Bartholin gland excision (glandectomy), we advise patients to plan for 10–14 days in-country, as this is a more extensive dissection with greater risk of hematoma and wound breakdown in the early post-operative period. The Word catheter, if left in situ per the standard 4–6 week protocol, can be removed by your local gynecologist at home after you return, and GAF Healthcare will arrange detailed written instructions and a video consultation with your home physician if needed. Your treating surgeon will issue a formal fit-to-fly certificate before discharge, which is required by most airlines for recent surgical patients.
Success rates for Bartholin's cyst treatment vary by procedure and are defined as freedom from recurrence at 12 months. Simple incision and drainage (I&D) alone has the lowest success rate—approximately 30–50%—due to rapid re-closure of the unlined cavity; it is therefore used only as an emergency measure. Word catheter insertion, the most widely used first-line surgical approach, achieves a 55–75% success rate after a single insertion, rising to approximately 80–85% with repeat insertion or extended catheter dwell time. Marsupialization—the creation of a permanent neo-ostium by suturing the everted cyst wall to the vaginal skin—is the gold-standard procedure with published success rates of 85–95% and recurrence rates of only 5–15% at 12 months; this makes it the preferred intervention for recurrent cysts. CO₂ laser marsupialization, available at select centers in India and the UAE, demonstrates equivalent or slightly superior outcomes with faster wound healing. Bartholin gland excision (glandectomy) offers the definitive cure with recurrence rates below 5%, as the entire secretory apparatus is removed; however, it carries higher procedural risk and is reserved for multiply-recurrent or histologically suspicious cases. The gynecologists at GAF Healthcare's partner hospitals are high-volume subspecialists in vulvar surgery, and institutional audits at these centers consistently report outcomes at the upper range of published benchmarks.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides comprehensive end-to-end medical travel coordination for international patients traveling to India or the UAE for Bartholin's cyst treatment.
INDIA LOGISTICS:
• e-Medical Visa Assistance: GAF Healthcare's visa coordination team prepares and submits the Indian e-Medical Visa application on the patient's behalf, including the mandatory hospital sponsorship letter from the treating NABH/JCI-accredited institution. The e-Medical Visa is typically issued within 3–5 business days and permits two companion (e-Medical Attendant) visas for accompanying family members.
• Recommended Partner Hospitals: Apollo Hospitals (Chennai, Delhi, Hyderabad), Fortis Memorial Research Institute (Gurugram), Manipal Hospitals (Bangalore), and Kokilaben Dhirubhai Ambani Hospital (Mumbai)—all NABH- and JCI-accredited with dedicated international patient services desks.
• Accommodation: GAF Healthcare arranges serviced apartments or hotel accommodation within 2–5 km of the treating hospital for the patient and one attendant, at pre-negotiated medical tourism rates.
UAE LOGISTICS:
• Visa Entry: Citizens of over 120 nationalities enjoy visa-free or visa-on-arrival entry to the UAE. For nationalities requiring advance visas, GAF Healthcare coordinates a 30-day UAE medical tourism visa through the hospital's international patient department in partnership with the General Directorate of Residency and Foreigners Affairs (GDRFA).
• Recommended Partner Hospitals: Mediclinic City Hospital (Dubai Healthcare City), Cleveland Clinic Abu Dhabi, King's College Hospital Dubai, and American Hospital Dubai—all JCI-accredited and licensed by the Dubai Health Authority (DHA) or Department of Health Abu Dhabi (DOH).
• Accommodation: GAF Healthcare partners with hotels adjacent to Dubai Healthcare City and Abu Dhabi's medical districts, offering discounted rates for medical travel patients and attendants.
SHARED SERVICES (INDIA & UAE):
• Dedicated bilingual case manager assigned from inquiry through discharge
• Airport-to-hospital-to-hotel private transfer service with medical escort if required
• On-ground interpreter services available in Arabic, Russian, French, Swahili, and other languages on request
• Remote pre-operative teleconsultation with the treating gynecologist arranged 1–2 weeks before arrival
• Assistance with international health insurance direct billing or preparation of itemized invoices for insurance reimbursement claims
• 24/7 emergency helpline for post-discharge clinical queries, connected to the treating hospital's gynecology on-call team
• Post-departure follow-up: GAF Healthcare coordinates teleconsultation appointments at 2 weeks and 6 weeks with the treating surgeon or a partner gynecologist in the patient's home country